Cipla Share Price Today
- All
- News
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Cipla Hits Record High On Pact To Import Moderna's Covid Vaccine
Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
Cipla, RCom, Reliance Capital in Focus Today
The Nifty opened lower on Monday as indicated by futures trade on Singapore Stock Exchange. Both foreign and domestic investors remained net buyers of Indian equities on Thursday. Foreign investors bought shares worth Rs 625 crore and domestic investors were net buyers to the tune of Rs 136 crore. Lower crude oil price is likely to boost sentiments...
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Cipla Hits Record High On Pact To Import Moderna's Covid Vaccine
Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.
-
Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
Cipla, RCom, Reliance Capital in Focus Today
The Nifty opened lower on Monday as indicated by futures trade on Singapore Stock Exchange. Both foreign and domestic investors remained net buyers of Indian equities on Thursday. Foreign investors bought shares worth Rs 625 crore and domestic investors were net buyers to the tune of Rs 136 crore. Lower crude oil price is likely to boost sentiments...
